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Problem Definition
Glucose metabolism is a complex process consisting of 
several physiologic mechanisms that function to regulate 
serum glucose levels and maintain them within a fairly 
narrow range in healthy individuals. Hypoglycemia is 
characterized by a reduction in plasma glucose 
concentration to a level low enough, typically less than 
60 mg/dL, to cause symptoms or systemic effects, 
classically adrenergic stimulation or altered mental 
status. Hypoglycemia is most frequently seen in patients 
with diabetes following insulin injection or intake of oral 
hypoglycemic agents. In the patient without diabetes, 
hypoglycemia is much less common and often warrants 
further investigation to determine the cause.
Hospitalized patients are high risk for hypoglycemia 
because acute and chronic illness can cause altered 
counterregulatory responses and the development of 
life-threatening sequelae. Controlling blood glucose in 
hospitalized patients is important as both hyperglycemia 
and hypoglycemia are associated with increased cost, 
length of stay, morbidity and mortality. Avoidance and 
recognition of hypoglycemia is essential to patient safety 
and studies have confirmed higher mortality rates with 
spontaneous rather than iatrogenic hypoglycemia. 
Therefore, hypoglycemia of unclear cause may be viewed 
as a biomarker systemic disease and mandates 
appropriate investigation to determine the etiology.
Aims For Improvement
It is the aim of our quality improvement project to create 
a standardized method to appropriately assess and 
treat hypoglycemia in the inpatient setting such that the 
needed components of the diagnostic evaluation can be 
obtained in an expedited, cost-effective and patient 
safety-oriented manner. We plan to design of an 
inpatient hypoglycemia order set which can be used as 
an easily accessible reference and clinical tool.
Intervention
To improve patient safety and diagnostic value of testing, we 
propose a provider-driven protocol for testing needed in evaluation 
of true hypoglycemia. The narrow investigative window in such 
instances, while blood glucose is still low prior to temporizing 
measures, often limits the opportunity to obtain the appropriate 
diagnostic testing. It is critically important to confirm that the 
plasma glucose is indeed low (<60 mg/dL). Serology for additional 
testing should be obtained simultaneously for use/analysis if 
hypoglycemia is confirmed. Whipple’s triad of low plasma glucose, 
symptoms of hypoglycemia at the time of the low glucose, and 
symptom relief with treatment of hypoglycemia should also be 
confirmed on all patients.
Such additional laboratory testing is directed at evaluation for 
potential hormone and metabolic imbalances, toxic ingestions, 
and/or enzymatic defects. This can be done via immediate blood 
draw of at least two gold-top tubes and labs ordered via protocol      
(as below).
Advanced testing, as included in our proposed order set, should 
include the following:
• Basic Metabolic Panel (plasma glucose, electrolytes)
• Plasma insulin levels, Pro-insulin levels, C-
peptide levels
• Serum lactate and ketones (beta-hydroxybutyrate 
where available), Urine ketones.
• Thyroid, adrenal (random cortisol), liver function tests
• We recommend obtaining both TSH and Free T4
• Cortisol level at the time of hypoglycemia is appropriate    
if >14 mcg/dL
• Spot sulfonylurea screen (send out)
• Toxicology screen (UDS, ethanol, salicylates), as appropriate.
Measurement and Results
In review of charts of 11 patients recently admitted to 
Thomas Jefferson University Hospital (TJUH) for whom 
a complete biochemical evaluation of hypoglycemia was 
obtained:
• 2/11 (18%) of evaluations yielded clinically significant 
data, 82% of initial testing was inconclusive (Fig 1.)
• 1/11 (9%) of patients for whom the workup 
was performed had true hypoglycemia (<60ngdL)
• 4/11 patients (36%) lacked confirmatory blood 
glucose levels (Fig 2)
• In almost half of all cases, testing had to be repeated.
(Fig 3.)
Next Steps and Lessons Learned
In reviewing data from hypoglycemia evaluations 
performed within our institution it is appears that the 
workup is often incomplete or yields uninterpretable 
results.
While this data is limited and represents a very small 
subset of patients, it is supportive of the need for a 
standardized institutional ‘hypoglycemic diagnostic 
protocol’ that will allow for staff to obtain all relevant 
laboratory data needed to complete the diagnostic 
workup without delaying treatment. We are confident 
that implementation of this simple, user-friendly and 
cost-effective protocol will lead to improved patient 
outcomes and institutional quality measures.
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